Picard Medical, Inc. (PMI) is a publicly traded the market company. As of May 21, 2026, PMI trades at $0.15 with a market cap of $15.82M and a P/E ratio of -2.90. PMI moved -6.13% today. Year to date, PMI is -90.78%; over the trailing twelve months it is flat. Its 52-week range spans $0.13 to $13.68. Rallies surfaces PMI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in PMI news today?
Picard Medical Q1 Revenue Rises 85% to $1.2M, Debt Cut to $1.3M: Picard Medical posted Q1 2026 revenue up 85% to $1.2 million, with product sales rising 54% to $0.9 million and gross profit $0.3 million at a 24% margin versus a $0.4 million loss. It cut its senior secured note to $1.3 million by repaying $9.5 million, raised $5 million in May and faces NYSE equity compliance notices.
ROACH JOHN D sold 10.87K (~$1.087) on Dec 21, 2011.
ROACH JOHN D sold 1.39K (~$42.069) on Dec 21, 2011.
ROACH JOHN D sold 1.50K (~$46.95) on Dec 21, 2011.
PMI Analyst Consensus
PMI analyst coverage data. Average price target: $0.00.
Common questions about PMI
What changed in PMI news today?
Picard Medical Q1 Revenue Rises 85% to $1.2M, Debt Cut to $1.3M: Picard Medical posted Q1 2026 revenue up 85% to $1.2 million, with product sales rising 54% to $0.9 million and gross profit $0.3 million at a 24% margin versus a $0.4 million loss. It cut its senior secured note to $1.3 million by repaying $9.5 million, raised $5 million in May and faces NYSE equity compliance notices.
Does Rallies summarize PMI news?
Yes. Rallies summarizes PMI news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is PMI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PMI. It does not provide personalized investment advice.
